CICON-23, 20-23 September, Milan Italy

CICON-23, 20-23 September, Milan Italy Doroteya Raykova will present our poster Unraveling the tumor microenvironment with spatial proteomics: in situ detection of immune checkpoint interactions in cancer patient tissues (PDF) at the CICON-23 Conference. Inge Cyrén, Area Manager for North America will also be representing Navinci. Please reach out to them if you want to book a…

Expanding Your Options with NaveniLink™

Expanding Your Options with NaveniLink™ Would you like to perform a proximity ligation assay using your own primary antibodies? Our NaveniLink conjugation kit allows you to do just that. You can use your primary antibodies and easily conjugate them with our proprietary oligonucleotide sequences. These conjugates can be seamlessly integrated into our Naveni® product line,…

Product Advancement: NaveniFlex™ Cell

Product Advancement: NaveniFlex™ Cell We know that diverse sample types demand tailored solutions. To maximize the value of your samples, we refined and optimized our Flexible offerings and aligned them closer to your needs. Introducing NaveniFlex Cell, an optimized advancement that builds upon the strong foundation of our NaveniFlex™ technology. This cutting-edge kit is meticulously…

NaveniFlex in Autophagy publication

NaveniFlex in Autophagy publication We’re excited to see that our Naveni® technology has been referenced in a fantastic publication describing novel insights into the process of lysosomal degradation of mitochondria (mitophagy) (Godtliebsen et al. 2023, Autophagy). The authors used ingenious double tagging of mitochondria, where the green signal was quenched at low pH, whereas red…

Cayman and Navinci Announce Strategic Partnership

Cayman and Navinci Announce Strategic Partnership Expanding Access to Next-Generation Tools for Spatial Proteomics Ann Arbor, MI – 07/05/2023 – Global life sciences supplier Cayman Chemical (Cayman) announced today a strategic partnership with Navinci Diagnostics (Navinci), a Swedish biotechnology company developing innovative tools for spatial proteomics. This partnership expands access to Navinci’s portfolio of proximity…

Illuminate PD1/PD-L1 interactions – new product out!

Illuminate PD1/PD-L1 interactions – new product out!  23-06-12 Uppsala Navinci expands its portfolio to unravel PD1 signaling, introducing the fluorescent assay, Naveni™ PD1/PD-L1 Atto 647N. With Naveni™ PD1/PD-L1 Atto 647N, you can now achieve a comprehensive visualization of the tumor microenvironment through co-staining. Illuminate PD1/PD-L1 interactions like never before and gain a deeper understanding of…

Spatial Biology US – latest innovations in spatial research & technologies

Navinci is a silver sponsor at Spatial Biology US 23-06-08 Uppsala Don’t miss the opportunity to meet our team consisting of Inge Cyrén (Area Manager North America), Subham Basu (CBO), and Doroteya Raykova (Applications Scientist).  Doroteya Raykova will present our latest advancements in spatial proteomics  (June 8th 12:40). She will explore the fascinating world of protein-protein interactions (PPIs) and shed light…

Spatial Biology UK – latest innovations in spatial research & technologies

Spatial Biology UK – latest innovations in spatial research & technologies  23-04-21 Uppsala Navinci is joining Spatial Biology UK an Oxford Global event in London April 25-26th , a 2-day event that explores spatial research: from the application of spatial technologies in biology through to topical updates from spatial genomics, transcriptomics, metabolomics and spatial bioinformatics.…

Navinci Diagnostics announces the appointment of Dr Subham Basu as new Chief Business Officer

Press release Navinci Diagnostics AB, a Swedish life science company developing innovative tools for spatial proteomics research, announces the appointment of Dr Subham Basu as new Chief Business Officer, effective April 11th 2023. Dr Subham Basu will join Navinci to lead the organizational build-up and international commercialization of the unique Navinci product portfolio for Spatial…

Navinci at AACR – new research data and product developments

Navinci at AACR – new research data and product developments  31-03-2023 Uppsala Navinci will attend AACR on April 14-19th in Orlando, US. We will showcase our latest product designs and tell you what is new in protein-protein interaction technology. You can find us in the exhibition hall (booth 1771) and at the scientific sessions with four poster presentations including…